Literature DB >> 7785462

Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins.

C C Pilbeam1, L G Raisz, O Voznesensky, C B Alander, B N Delman, H Kawaguchi.   

Abstract

Prostaglandins (PGs) have been postulated to amplify their own production by stimulating cyclic adenosine monophosphate activity, which in turn stimulates PG production. We examined regulation of messenger RNA levels for the inducible and constitutive prostaglandin G/H synthases, PGHS-2 and PGHS-1, in murine osteoblastic MC3T3-E1 cells, which express both PGHS-1 and PGHS-2, and in rat osteoblastic Py1a cells, which express only PGHS-2. Prostaglandins E2, F2 alpha, and D2 induced PGHS-2 mRNA in both cell lines under serum-free conditions and stimulated small increases in PGHS-1 mRNA levels in MC3T3-E1 cells. PGE2 (1 microM) increased the transcription rate of PGHS-2 mRNA 9-fold at 2 h in serum-free cells and also induced PGHS-2 protein. In the presence of arachidonic acid or serum, PGs also increased medium PGE2. Both forskolin, a protein kinase A activator, and phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, have previously been shown to induce PGHS-2 mRNA in MC3T3-E1 cells, but in the present study only PMA induced PGHS-2 expression in Py1a cells. The induction of PGHS-2 mRNA in Py1a cells by PGs was inhibited by chelerythrine, a PKC inhibitor, and blocked by 24 h of pretreatment with PMA. The 2 h serum stimulation of PGHS-2 mRNA in MC3T3-E1 cells was inhibited 40-50% by three structurally unrelated nonsteroidal anti-inflammatory drugs (NSAIDs), suggesting that endogenous PGs also amplify PG production through induction of PGHS-2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785462     DOI: 10.1002/jbmr.5650100311

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Short-term supplementation of COX-2 inhibitor suppresses bone turnover in gonad-intact middle-aged male rats.

Authors:  Chwan-Li Shen; James K Yeh; Xingjia Wang
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.

Authors:  Zheng Xu; Shilpa Choudhary; Yosuke Okada; Olga Voznesensky; Cynthia Alander; Lawrence Raisz; Carol Pilbeam
Journal:  Bone       Date:  2007-03-21       Impact factor: 4.398

3.  Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.

Authors:  H Kawaguchi; C C Pilbeam; G Gronowicz; C Abreu; B S Fletcher; H R Herschman; L G Raisz; M M Hurley
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

4.  Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells.

Authors:  Y Chen; M Hughes-Fulford
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

5.  Cyclooxygenase-2 and its regulation in inflammation.

Authors:  Y S Bakhle; R M Botting
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

6.  Compensatory cellular reactions to nonsteroidal anti-inflammatory drugs on osteogenic differentiation in canine bone marrow-derived mesenchymal stem cells.

Authors:  Namgil Oh; Sangho Kim; Kenji Hosoya; Masahiro Okumura
Journal:  J Vet Med Sci       Date:  2014-01-13       Impact factor: 1.267

Review 7.  Toxicological characterization of phthalic Acid.

Authors:  Du Yeon Bang; In Kyung Lee; Byung-Mu Lee
Journal:  Toxicol Res       Date:  2011-12

8.  Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.

Authors:  Shilpa Choudhary; Katherine Blackwell; Olga Voznesensky; Abhijit Deb Roy; Carol Pilbeam
Journal:  Bone       Date:  2013-04-29       Impact factor: 4.398

9.  Fluid shear stress induces osteoblast differentiation and arrests the cell cycle at the G0 phase via the ERK1/2 pathway.

Authors:  Liyin Yu; Xingfeng Ma; Junqin Sun; Jie Tong; Liang Shi; Lijun Sun; Jianbao Zhang
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.